SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-013876
Filing Date
2021-03-17
Accepted
2021-03-17 16:23:37
Documents
75
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrca-10k_20201231.htm   iXBRL 10-K 3307019
2 EX-10.21 vrca-ex1021_65.htm EX-10.21 108357
3 EX-10.22 vrca-ex1022_66.htm EX-10.22 151345
4 EX-23.1 vrca-ex231_7.htm EX-23.1 4345
5 EX-31.1 vrca-ex311_9.htm EX-31.1 17081
6 EX-31.2 vrca-ex312_13.htm EX-31.2 16999
7 EX-32.1 vrca-ex321_10.htm EX-32.1 10063
8 GRAPHIC g4p4tcgujyqk000001.jpg GRAPHIC 29030
  Complete submission text file 0001564590-21-013876.txt   10301398

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vrca-20201231.xsd EX-101.SCH 56521
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20201231_cal.xml EX-101.CAL 59417
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20201231_def.xml EX-101.DEF 219110
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20201231_lab.xml EX-101.LAB 503278
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20201231_pre.xml EX-101.PRE 377376
14 EXTRACTED XBRL INSTANCE DOCUMENT vrca-10k_20201231_htm.xml XML 1621420
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38529 | Film No.: 21750838
SIC: 2834 Pharmaceutical Preparations